G Griesinger, C Blockeel, E Kahler, C Pexman-Fieth… - PLoS …, 2020 - journals.plos.org
The aim of this systematic review and meta-analysis was to conduct a comprehensive assessment of the evidence on the efficacy and safety of oral dydrogesterone versus …
The physical and psychological effect of miscarriage is commonly underappreciated. The journey from diagnosis of miscarriage, through clinical management, to supportive aftercare …
G Griesinger, C Blockeel, GT Sukhikh… - Human …, 2018 - academic.oup.com
STUDY QUESTION Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY …
The pharmacological and physiological profiles of progestogens used for luteal phase support during assisted reproductive technology are likely to be important in guiding clinical …
STUDY QUESTION Does the addition of oral dydrogesterone to vaginal progesterone as luteal phase support improve pregnancy outcomes during frozen embryo transfer (FET) …
No data support the suggestion that first-trimester dydrogesterone use increases the risk of foetal abnormalities; however, two low-quality retrospective studies (one retracted by the …
PCM Piette - Best Practice & Research Clinical Obstetrics & …, 2020 - Elsevier
Natural progesterone (P4) has a unique pharmacodynamic activity and safety profile compared to the synthetic progestins. As a result, a class effect does not exist for both P4 …
J Huang, Q Xie, J Lin, X Lu, N Wang… - Drug Design …, 2019 - Taylor & Francis
Purpose Dydrogesterone (DYG) has been demonstrated to be an alternative progestin in the progestin-primed ovarian stimulation (PPOS) protocol with comparable oocyte retrieval and …